Related references
Note: Only part of the references are listed.Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer
Xinlei Hu et al.
CLINICAL EPIGENETICS (2022)
Participation and Yield of a Lung Cancer Screening Program in Hebei, China
Di Liang et al.
FRONTIERS IN ONCOLOGY (2022)
Non-Small Cell Lung Cancer, Version 3.2022
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
LRP1B: A Giant Lost in Cancer Translation
Catarina Principe et al.
PHARMACEUTICALS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes
Kathryn Davidson et al.
CELL DEATH & DISEASE (2021)
Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma
Brian C. -H. Chiu et al.
NPJ GENOMIC MEDICINE (2021)
Screening for Lung Cancer CHEST Guideline and Expert Panel Report
Peter J. Mazzone et al.
CHEST (2021)
Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma
Lu Ao et al.
LUNG CANCER (2021)
Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test
Wenhua Liang et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma
Mark A. Applebaum et al.
CLINICAL CANCER RESEARCH (2020)
Barriers to Low-Dose CT Lung Cancer Screening among Middle-Aged Chinese
Qike Jia et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation
Xiao-Long Cui et al.
NATURE COMMUNICATIONS (2020)
Patient Adherence to Screening for Lung Cancer in the US A Systematic Review and Meta-analysis
Maria A. Lopez-Olivo et al.
JAMA NETWORK OPEN (2020)
Trends and risk factors of lung cancer in China
Siyi He et al.
CHINESE JOURNAL OF CANCER RESEARCH (2020)
5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes
Ying Yang et al.
CLINICAL CHEMISTRY (2019)
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma
Brian C-H Chiu et al.
BLOOD ADVANCES (2019)
Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
Chang Zeng et al.
CANCER COMMUNICATIONS (2019)
CEMiTool: a Bioconductor package for performing comprehensive modular co-expression analyses
Pedro S. T. Russo et al.
BMC BIOINFORMATICS (2018)
Urban-rural disparities in health care utilization among Chinese adults from 1993 to 2011
Jiajia Li et al.
BMC HEALTH SERVICES RESEARCH (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Lung Cancer Screening, Version 3.2018
Douglas E. Wood et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Qixian Yang et al.
DISEASE MARKERS (2018)
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
Chun-Xiao Song et al.
CELL RESEARCH (2017)
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
Wenshuai Li et al.
CELL RESEARCH (2017)
KEGG as a reference resource for gene and protein annotation
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2016)
A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell Populations
Dali Han et al.
MOLECULAR CELL (2016)
Integrative analysis of 111 reference human epigenomes
Anshul Kundaje et al.
NATURE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Attitudes and Beliefs Toward Lung Cancer Screening Among US Veterans
Nichole T. Tanner et al.
CHEST (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Uncovering the role of 5-hydroxymethylcytosine in the epigenome
Miguel R. Branco et al.
NATURE REVIEWS GENETICS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine
Chun-Xiao Song et al.
NATURE BIOTECHNOLOGY (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Biomarkers in lung cancer: from early detection to novel therapeutics and decision making
April Scott et al.
BIOMARKERS IN MEDICINE (2008)
Regularization and variable selection via the elastic net
H Zou et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2005)
LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p2l.3, binds pRB and represses E2F-driven transcription
TV Sharp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
